Source:http://linkedlifedata.com/resource/pubmed/id/16313945
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2006-2-13
|
pubmed:abstractText |
The nonagenarian population by definition represents individuals who have demonstrated success in aging. We determined the status of CD8(+) T-cell senescence in nonagenarians by analyzing the expression of CD28 and Fas (CD95), and analyzing activation and activation-induced cell death (AICD). Peripheral blood mononuclear cells (PBMCs) were isolated from three groups of subjects: adults (20-64-year-old), older adults (65-89-year-old), and nonagenarians (>or=90-year-old). PBMCs were stimulated with phytohemagglutinin (PHA) (10 microg/ml). The cells were labeled with conjugated antibodies specific for CD4, CD8, CD28, CD45RO, and Fas, and were analyzed by FACS((R)). There was a strong negative correlation of the percentage of CD28(+)Fas(-) CD8(+) T-cells with the age of each individual prior to stimulation in vitro (R(2)=0.76, p<0.0001). Compared to other biomarkers (CD28(-), CD28(-)CD45RO(+), and Fas(+)) that have been associated with CD8(+) T-cell aging, the loss of the CD28(+)Fas(-) CD8(+) T-cell population exhibited the strongest correlation with the individual's chronologic age. After stimulation with PHA, there was a decrease in the percentage of CD8(+) T-cells from individual >or=65-year-old that expresses both CD28(+) and Fas(+) at day 3. Surprisingly, the AICD response of CD8(+) T-cells at day 7 in the nonagenarians was higher than that in the other two groups. These results suggest that successful aging does not prevent development of the senescent phenotype of unstimulated CD8(+) T cells, but is associated with preservation of CD8 T cell functions including activation and AICD. Increased AICD may result in enhanced rejuvenation capacity of T cells and limit the impact of aging on T cell function in nonagenarians.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0047-6374
|
pubmed:author |
pubmed-author:GeraldLynn BLB,
pubmed-author:HsuHui-ChenHC,
pubmed-author:JazwinskiS MichalSM,
pubmed-author:LEAM AMA,
pubmed-author:Louisiana Healthy Aging Study,
pubmed-author:MountzJohn DJD,
pubmed-author:RavussinEricE,
pubmed-author:SchroederHarry WHWJr,
pubmed-author:ScottDonald KDK,
pubmed-author:YangPingArP,
pubmed-author:ZhangPiliP,
pubmed-author:ZhouJulingJ
|
pubmed:issnType |
Print
|
pubmed:volume |
127
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
231-9
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:16313945-Adult,
pubmed-meshheading:16313945-Aging,
pubmed-meshheading:16313945-Antigens, CD28,
pubmed-meshheading:16313945-Antigens, CD95,
pubmed-meshheading:16313945-Apoptosis,
pubmed-meshheading:16313945-Biological Markers,
pubmed-meshheading:16313945-CD8-Positive T-Lymphocytes,
pubmed-meshheading:16313945-Cells, Cultured,
pubmed-meshheading:16313945-Female,
pubmed-meshheading:16313945-Gene Expression Regulation,
pubmed-meshheading:16313945-Humans,
pubmed-meshheading:16313945-Lymphocyte Activation,
pubmed-meshheading:16313945-Male,
pubmed-meshheading:16313945-Middle Aged,
pubmed-meshheading:16313945-Phytohemagglutinins
|
pubmed:year |
2006
|
pubmed:articleTitle |
CD8 T-cell immune phenotype of successful aging.
|
pubmed:affiliation |
The University of Alabama at Birmingham, Department of Medicine, Division of Clinical Immunology Rheumatology, 701 South 19th Street, LHRB 473, Birmingham, AL 35294, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, Non-P.H.S.,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|